Previous 10 | Next 10 |
home / stock / cvs / cvs articles
Corporate earnings came to the market’s rescue in the past week, helping to overcome rate fears. As we look ahead to the unfolding week, it r...
On Thursday, Evernorth Health Services said its Accredo arm will make a Humira biosimilar available to patients with no out-of-pocket costs. Eve...
On CNBC’s "Halftime Report Final Trades," Joshua Brown of Ritholtz Wealth Management said AppLovin Corporation (NASDAQ: APP) is th...
SOUTHFIELD, Mich., April 9, 2024 /PRNewswire/ -- Aetna Better Health of Michigan, a CVS Health® company (NYSE:CVS), has been recommended by ...
Last week's stellar first-quarter finish was followed up by a fairly brutal start to the month, particularly for the Dow Jones Industrial Avera...
CVS Health Corp (NYSE:CVS) on Thursday revealed that its drug plans will cover the first over-the-counter birth control pill in the U.S. witho...
Shares of Stryve Foods, Inc. (NASDAQ: SNAX) fell sharply during Tuesday’s session following a fourth-quarter revenue miss. Stryve Foods post...
U.S. stocks are expected to open lower on Tuesday, as worries from Monday’s session seem to carry over. Investors will be closely watching ...
U.S. stock futures were lower this morning, with the Dow futures falling by over 100 points on Tuesday. Shares of PVH Corp. (NYSE: PVH) fell shar...
News, Short Squeeze, Breakout and More Instantly...
2024-06-30 06:35:00 ET CVS Health (NYSE: CVS) is a top pharmacy retailer in the U.S., and over the years, it has been expanding its operations to go deeper into healthcare. The stock also provides investors with a dividend that yields 4.3%, which is more than double the S&P 50...
2024-06-27 21:02:00 ET CVS Health (NYSE: CVS) stock price is imploding as concerns about the pharmacy business continue. It has already plunged by more than 43% from its 2022 highs and is hovering at its lowest point since November 2020. Pharmacy woes are continuing The pharmacy...
2024-06-20 08:00:10 ET Andrew Mok from Barclays issued a price target of $65.00 for CVS on 2024-06-20 07:01:00. The adjusted price target was set to $65.00. At the time of the announcement, CVS was trading at $61.01. The overall price target consensus is at $109.15 with ...